February 21, 2015 / 9:29 PM / 3 years ago

Valeant nears deal to buy Salix for about $10 billion: WSJ

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014. REUTERS/Christinne Muschi

(Reuters) - Valeant Pharmaceuticals International (VRX.TO) is near a deal to buy Salix Pharmaceuticals Ltd SLXP.O for about $10 billion, the Wall Street Journal reported on Saturday.

Reporting by Eric Beech

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below